Tang, Y., Xuan, Y., Qiao, G., Ou, Z., He, Z., Zhu, Q., . . . Yin, G. (2019). MDM2 promotes epithelial–mesenchymal transition through activation of Smad2/3 signaling pathway in lung adenocarcinoma. Onco Targets Ther.
Chicago-стиль цитированияTang, Yong, Yiwen Xuan, Guibin Qiao, Zhu’an Ou, Zhe He, Qihang Zhu, Ming Liao, and Guilin Yin. "MDM2 Promotes Epithelial–mesenchymal Transition Through Activation of Smad2/3 Signaling Pathway in Lung Adenocarcinoma." Onco Targets Ther 2019.
MLA-цитированиеTang, Yong, et al. "MDM2 Promotes Epithelial–mesenchymal Transition Through Activation of Smad2/3 Signaling Pathway in Lung Adenocarcinoma." Onco Targets Ther 2019.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.